These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 7879309)

  • 1. [Neuromuscular blockade. Dosage of nondepolarizing agents to risk-group patients].
    Holst PE; Ostergaard D; Bonde J
    Ugeskr Laeger; 1995 Feb; 157(8):1051-5. PubMed ID: 7879309
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of nondepolarizing neuromuscular blocking agents in mechanically ventilated patients.
    Buck ML; Reed MD
    Clin Pharm; 1991 Jan; 10(1):32-48. PubMed ID: 1825627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of the nondepolarizing neuromuscular relaxants applied to calculation of bolus and infusion dosage regimens.
    Shanks CA
    Anesthesiology; 1986 Jan; 64(1):72-86. PubMed ID: 2935053
    [No Abstract]   [Full Text] [Related]  

  • 4. Factors influencing the profile of onset of relaxation.
    De Mey JC; De Laat M
    Acta Anaesthesiol Belg; 1997; 48(1):7-10. PubMed ID: 9099302
    [No Abstract]   [Full Text] [Related]  

  • 5. A comparative study of pharmacokinetics and pharmacodynamics of vecuronium in children and adults.
    Xue F; Liu Q; Zou Q; Luo L
    Chin Med J (Engl); 1998 Jan; 111(1):84-5. PubMed ID: 10322663
    [No Abstract]   [Full Text] [Related]  

  • 6. Rocuronium bromide and organ function.
    Bevan DR
    Eur J Anaesthesiol Suppl; 1994; 9():87-91. PubMed ID: 7925215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance to nondepolarizing neuromuscular blocking agents.
    Tschida SJ; Graupe KJ; Hoey LL; Vance-Bryan K
    Pharmacotherapy; 1996; 16(3):409-18. PubMed ID: 8726599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of time of day on the duration of neuromuscular blockade elicited by rocuronium.
    Cheeseman JF; Merry AF; Pawley MD; de Souza RL; Warman GR
    Anaesthesia; 2007 Nov; 62(11):1114-20. PubMed ID: 17924891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of implementation of neuromuscular blockade monitoring standards in a surgical intensive care unit.
    Frankel H; Jeng J; Tilly E; St Andre A; Champion H
    Am Surg; 1996 Jun; 62(6):503-6. PubMed ID: 8651538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effect of clonidine on the duration of vecuronium-induced neuromuscular blockade in humans].
    Nakahara T; Akazawa T; Kinoshita Y; Nozaki J
    Masui; 1995 Nov; 44(11):1458-63. PubMed ID: 8544280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rocuronium 0.3 mg x kg-1 (ED95) induces a normal peak effect but an altered time course of neuromuscular block in patients with Duchenne's muscular dystrophy.
    Muenster T; Schmidt J; Wick S; Forst J; Schmitt HJ
    Paediatr Anaesth; 2006 Aug; 16(8):840-5. PubMed ID: 16884467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuromuscular pharmacodynamics of rocuronium in patients with major burns.
    Han T; Kim H; Bae J; Kim K; Martyn JA
    Anesth Analg; 2004 Aug; 99(2):386-92, table of contents. PubMed ID: 15271712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Target controlled infusion of rocuronium: selection of a pharmacokinetic model.
    Vermeyen KM; Hoffmann VL; Saldien V; Adriaensen HF
    Acta Anaesthesiol Belg; 2002; 53(1):17-9. PubMed ID: 11975424
    [No Abstract]   [Full Text] [Related]  

  • 14. The neuromuscular effects of 0.6 mg kg(-1) rocuronium in elderly and young adults with or without renal failure.
    Kocabas S; Yedicocuklu D; Askar FZ
    Eur J Anaesthesiol; 2008 Nov; 25(11):940-6. PubMed ID: 18538050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-lasting potentiation of a single-dose of rocuronium by amikacin: case report.
    Gilliard V; Delvaux B; Russell K; Dubois PE
    Acta Anaesthesiol Belg; 2006; 57(2):157-9. PubMed ID: 16916186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prolonged neuromuscular blockade caused by mivacurium in a pediatric patient].
    Fernández-Rosado B; Vázquez-Fidalgo A; Pensado-Castiñeiras A; Figueira-Moure A; Rama-Maceiras P; Pose-Cambeiro P
    Rev Esp Anestesiol Reanim; 1999 Feb; 46(2):92. PubMed ID: 10100446
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of intermittent hemodialysis on nondepolarizing skeletal muscle relaxants.
    Cerulli J; Gailey RA; Low CL; Bailie GR
    Ann Pharmacother; 1997 May; 31(5):635-7. PubMed ID: 9161662
    [No Abstract]   [Full Text] [Related]  

  • 18. Sedation after intubation using etomidate and a long-acting neuromuscular blocker.
    Kendrick DB; Monroe KW; Bernard DW; Tofil NM
    Pediatr Emerg Care; 2009 Jun; 25(6):393-6. PubMed ID: 19458564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacodynamics of rocuronium 0.3 mg kg(-1) in adult patients with and without renal failure.
    Robertson EN; Driessen JJ; Vogt M; De Boer H; Scheffer GJ
    Eur J Anaesthesiol; 2005 Dec; 22(12):929-32. PubMed ID: 16318664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Onset and duration of mivacurium-induced neuromuscular blockade in children with Charcot-Marie-Tooth disease. A case series with five children.
    Schmitt HJ; Wick S; Münster T
    Paediatr Anaesth; 2006 Feb; 16(2):182-7. PubMed ID: 16430417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.